カテゴリー： Market Monitor Global, 世界, 医療/バイオ

禁煙用ニコチン代替療法のグローバル市場展望 2023年-2029年：スプレー＆吸入器、ガム、パッチ、トローチ

◆英語タイトル：Nicotine Replacement Therapy for Smoking Cessation Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23DC16166）

◆商品コード：MMG23DC16166
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年12月
◆ページ数：61
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の禁煙用ニコチン代替療法市場規模と予測を収録しています。・世界の禁煙用ニコチン代替療法市場：売上、2018年-2023年、2024年-2029年
・世界の禁煙用ニコチン代替療法市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の禁煙用ニコチン代替療法市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「スプレー＆吸入器」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

禁煙用ニコチン代替療法のグローバル主要企業は、Pfizer、 Cipla、 Novartis、 GlaxoSmithKline、 Johnson & Johnson、 Philip Morris、 Perrigo Company、 Alkalon、 Ventus Medicalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、禁煙用ニコチン代替療法のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の禁煙用ニコチン代替療法市場：タイプ別、2018年-2023年、2024年-2029年
世界の禁煙用ニコチン代替療法市場：タイプ別市場シェア、2022年
・スプレー＆吸入器、ガム、パッチ、トローチ

世界の禁煙用ニコチン代替療法市場：用途別、2018年-2023年、2024年-2029年
世界の禁煙用ニコチン代替療法市場：用途別市場シェア、2022年
・薬局、スーパー、病院、その他

世界の禁煙用ニコチン代替療法市場：地域・国別、2018年-2023年、2024年-2029年
世界の禁煙用ニコチン代替療法市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における禁煙用ニコチン代替療法のグローバル売上、2018年-2023年
・主要企業における禁煙用ニコチン代替療法のグローバル売上シェア、2022年
・主要企業における禁煙用ニコチン代替療法のグローバル販売量、2018年-2023年
・主要企業における禁煙用ニコチン代替療法のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Pfizer、 Cipla、 Novartis、 GlaxoSmithKline、 Johnson & Johnson、 Philip Morris、 Perrigo Company、 Alkalon、 Ventus Medical

*************************************************************

・調査・分析レポートの概要
禁煙用ニコチン代替療法市場の定義
市場セグメント
世界の禁煙用ニコチン代替療法市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の禁煙用ニコチン代替療法市場規模
世界の禁煙用ニコチン代替療法市場規模：2022年 VS 2029年
世界の禁煙用ニコチン代替療法市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの禁煙用ニコチン代替療法の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の禁煙用ニコチン代替療法製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：スプレー＆吸入器、ガム、パッチ、トローチ
禁煙用ニコチン代替療法のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：薬局、スーパー、病院、その他
禁煙用ニコチン代替療法の用途別グローバル売上・予測

・地域別市場分析
地域別禁煙用ニコチン代替療法市場規模 2022年と2029年
地域別禁煙用ニコチン代替療法売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Pfizer、 Cipla、 Novartis、 GlaxoSmithKline、 Johnson & Johnson、 Philip Morris、 Perrigo Company、 Alkalon、 Ventus Medical
...

This research report provides a comprehensive analysis of the Nicotine Replacement Therapy for Smoking Cessation market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Nicotine Replacement Therapy for Smoking Cessation market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Nicotine Replacement Therapy for Smoking Cessation, challenges faced by the industry, and potential opportunities for market players.
The global Nicotine Replacement Therapy for Smoking Cessation market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Nicotine Replacement Therapy for Smoking Cessation market presents opportunities for various stakeholders, including Pharmacy, Supermarket. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Nicotine Replacement Therapy for Smoking Cessation market. Additionally, the growing consumer demand present avenues for market expansion.
The global Nicotine Replacement Therapy for Smoking Cessation market was valued at US$ 494.2 million in 2022 and is projected to reach US$ 696 million by 2029, at a CAGR of 5.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Nicotine Replacement Therapy for Smoking Cessation market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Nicotine Replacement Therapy for Smoking Cessation market.
Market Overview: The report provides a comprehensive overview of the Nicotine Replacement Therapy for Smoking Cessation market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Sprays and Inhalers, Gums), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Nicotine Replacement Therapy for Smoking Cessation market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Nicotine Replacement Therapy for Smoking Cessation market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Nicotine Replacement Therapy for Smoking Cessation market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Nicotine Replacement Therapy for Smoking Cessation market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Nicotine Replacement Therapy for Smoking Cessation market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Nicotine Replacement Therapy for Smoking Cessation market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Nicotine Replacement Therapy for Smoking Cessation, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Nicotine Replacement Therapy for Smoking Cessation market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Nicotine Replacement Therapy for Smoking Cessation market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Sprays and Inhalers
Gums
Patches
Lozenges
Market segment by Application
Pharmacy
Supermarket
Hospital
Other
Global Nicotine Replacement Therapy for Smoking Cessation Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Pfizer
Cipla
Novartis
GlaxoSmithKline
Johnson & Johnson
Philip Morris
Perrigo Company
Alkalon
Ventus Medical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nicotine Replacement Therapy for Smoking Cessation, market overview.
Chapter 2: Global Nicotine Replacement Therapy for Smoking Cessation market size in revenue.
Chapter 3: Detailed analysis of Nicotine Replacement Therapy for Smoking Cessation company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nicotine Replacement Therapy for Smoking Cessation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Nicotine Replacement Therapy for Smoking Cessation Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nicotine Replacement Therapy for Smoking Cessation Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nicotine Replacement Therapy for Smoking Cessation Overall Market Size
2.1 Global Nicotine Replacement Therapy for Smoking Cessation Market Size: 2022 VS 2029
2.2 Global Nicotine Replacement Therapy for Smoking Cessation Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Nicotine Replacement Therapy for Smoking Cessation Players in Global Market
3.2 Top Global Nicotine Replacement Therapy for Smoking Cessation Companies Ranked by Revenue
3.3 Global Nicotine Replacement Therapy for Smoking Cessation Revenue by Companies
3.4 Top 3 and Top 5 Nicotine Replacement Therapy for Smoking Cessation Companies in Global Market, by Revenue in 2022
3.5 Global Companies Nicotine Replacement Therapy for Smoking Cessation Product Type
3.6 Tier 1, Tier 2 and Tier 3 Nicotine Replacement Therapy for Smoking Cessation Players in Global Market
3.6.1 List of Global Tier 1 Nicotine Replacement Therapy for Smoking Cessation Companies
3.6.2 List of Global Tier 2 and Tier 3 Nicotine Replacement Therapy for Smoking Cessation Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Nicotine Replacement Therapy for Smoking Cessation Market Size Markets, 2022 & 2029
4.1.2 Sprays and Inhalers
4.1.3 Gums
4.1.4 Patches
4.1.5 Lozenges
4.2 By Type – Global Nicotine Replacement Therapy for Smoking Cessation Revenue & Forecasts
4.2.1 By Type – Global Nicotine Replacement Therapy for Smoking Cessation Revenue, 2018-2023
4.2.2 By Type – Global Nicotine Replacement Therapy for Smoking Cessation Revenue, 2024-2029
4.2.3 By Type – Global Nicotine Replacement Therapy for Smoking Cessation Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Nicotine Replacement Therapy for Smoking Cessation Market Size, 2022 & 2029
5.1.2 Pharmacy
5.1.3 Supermarket
5.1.4 Hospital
5.1.5 Other
5.2 By Application – Global Nicotine Replacement Therapy for Smoking Cessation Revenue & Forecasts
5.2.1 By Application – Global Nicotine Replacement Therapy for Smoking Cessation Revenue, 2018-2023
5.2.2 By Application – Global Nicotine Replacement Therapy for Smoking Cessation Revenue, 2024-2029
5.2.3 By Application – Global Nicotine Replacement Therapy for Smoking Cessation Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Nicotine Replacement Therapy for Smoking Cessation Market Size, 2022 & 2029
6.2 By Region – Global Nicotine Replacement Therapy for Smoking Cessation Revenue & Forecasts
6.2.1 By Region – Global Nicotine Replacement Therapy for Smoking Cessation Revenue, 2018-2023
6.2.2 By Region – Global Nicotine Replacement Therapy for Smoking Cessation Revenue, 2024-2029
6.2.3 By Region – Global Nicotine Replacement Therapy for Smoking Cessation Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Nicotine Replacement Therapy for Smoking Cessation Revenue, 2018-2029
6.3.2 US Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.3.3 Canada Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.3.4 Mexico Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Nicotine Replacement Therapy for Smoking Cessation Revenue, 2018-2029
6.4.2 Germany Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.4.3 France Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.4.4 U.K. Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.4.5 Italy Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.4.6 Russia Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.4.7 Nordic Countries Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.4.8 Benelux Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Nicotine Replacement Therapy for Smoking Cessation Revenue, 2018-2029
6.5.2 China Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.5.3 Japan Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.5.4 South Korea Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.5.5 Southeast Asia Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.5.6 India Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Nicotine Replacement Therapy for Smoking Cessation Revenue, 2018-2029
6.6.2 Brazil Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.6.3 Argentina Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Nicotine Replacement Therapy for Smoking Cessation Revenue, 2018-2029
6.7.2 Turkey Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.7.3 Israel Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.7.4 Saudi Arabia Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.7.5 UAE Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
7 Nicotine Replacement Therapy for Smoking Cessation Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Nicotine Replacement Therapy for Smoking Cessation Major Product Offerings
7.1.4 Pfizer Nicotine Replacement Therapy for Smoking Cessation Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Cipla
7.2.1 Cipla Company Summary
7.2.2 Cipla Business Overview
7.2.3 Cipla Nicotine Replacement Therapy for Smoking Cessation Major Product Offerings
7.2.4 Cipla Nicotine Replacement Therapy for Smoking Cessation Revenue in Global Market (2018-2023)
7.2.5 Cipla Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Nicotine Replacement Therapy for Smoking Cessation Major Product Offerings
7.3.4 Novartis Nicotine Replacement Therapy for Smoking Cessation Revenue in Global Market (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Nicotine Replacement Therapy for Smoking Cessation Major Product Offerings
7.4.4 GlaxoSmithKline Nicotine Replacement Therapy for Smoking Cessation Revenue in Global Market (2018-2023)
7.4.5 GlaxoSmithKline Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Nicotine Replacement Therapy for Smoking Cessation Major Product Offerings
7.5.4 Johnson & Johnson Nicotine Replacement Therapy for Smoking Cessation Revenue in Global Market (2018-2023)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 Philip Morris
7.6.1 Philip Morris Company Summary
7.6.2 Philip Morris Business Overview
7.6.3 Philip Morris Nicotine Replacement Therapy for Smoking Cessation Major Product Offerings
7.6.4 Philip Morris Nicotine Replacement Therapy for Smoking Cessation Revenue in Global Market (2018-2023)
7.6.5 Philip Morris Key News & Latest Developments
7.7 Perrigo Company
7.7.1 Perrigo Company Company Summary
7.7.2 Perrigo Company Business Overview
7.7.3 Perrigo Company Nicotine Replacement Therapy for Smoking Cessation Major Product Offerings
7.7.4 Perrigo Company Nicotine Replacement Therapy for Smoking Cessation Revenue in Global Market (2018-2023)
7.7.5 Perrigo Company Key News & Latest Developments
7.8 Alkalon
7.8.1 Alkalon Company Summary
7.8.2 Alkalon Business Overview
7.8.3 Alkalon Nicotine Replacement Therapy for Smoking Cessation Major Product Offerings
7.8.4 Alkalon Nicotine Replacement Therapy for Smoking Cessation Revenue in Global Market (2018-2023)
7.8.5 Alkalon Key News & Latest Developments
7.9 Ventus Medical
7.9.1 Ventus Medical Company Summary
7.9.2 Ventus Medical Business Overview
7.9.3 Ventus Medical Nicotine Replacement Therapy for Smoking Cessation Major Product Offerings
7.9.4 Ventus Medical Nicotine Replacement Therapy for Smoking Cessation Revenue in Global Market (2018-2023)
7.9.5 Ventus Medical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Nicotine Replacement Therapy for Smoking Cessation Market Opportunities & Trends in Global Market
Table 2. Nicotine Replacement Therapy for Smoking Cessation Market Drivers in Global Market
Table 3. Nicotine Replacement Therapy for Smoking Cessation Market Restraints in Global Market
Table 4. Key Players of Nicotine Replacement Therapy for Smoking Cessation in Global Market
Table 5. Top Nicotine Replacement Therapy for Smoking Cessation Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Nicotine Replacement Therapy for Smoking Cessation Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Nicotine Replacement Therapy for Smoking Cessation Revenue Share by Companies, 2018-2023
Table 8. Global Companies Nicotine Replacement Therapy for Smoking Cessation Product Type
Table 9. List of Global Tier 1 Nicotine Replacement Therapy for Smoking Cessation Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nicotine Replacement Therapy for Smoking Cessation Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Nicotine Replacement Therapy for Smoking Cessation Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Nicotine Replacement Therapy for Smoking Cessation Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Nicotine Replacement Therapy for Smoking Cessation Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Nicotine Replacement Therapy for Smoking Cessation Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Nicotine Replacement Therapy for Smoking Cessation Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Nicotine Replacement Therapy for Smoking Cessation Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Company Summary
Table 31. Pfizer Nicotine Replacement Therapy for Smoking Cessation Product Offerings
Table 32. Pfizer Nicotine Replacement Therapy for Smoking Cessation Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Cipla Company Summary
Table 35. Cipla Nicotine Replacement Therapy for Smoking Cessation Product Offerings
Table 36. Cipla Nicotine Replacement Therapy for Smoking Cessation Revenue (US$, Mn) & (2018-2023)
Table 37. Cipla Key News & Latest Developments
Table 38. Novartis Company Summary
Table 39. Novartis Nicotine Replacement Therapy for Smoking Cessation Product Offerings
Table 40. Novartis Nicotine Replacement Therapy for Smoking Cessation Revenue (US$, Mn) & (2018-2023)
Table 41. Novartis Key News & Latest Developments
Table 42. GlaxoSmithKline Company Summary
Table 43. GlaxoSmithKline Nicotine Replacement Therapy for Smoking Cessation Product Offerings
Table 44. GlaxoSmithKline Nicotine Replacement Therapy for Smoking Cessation Revenue (US$, Mn) & (2018-2023)
Table 45. GlaxoSmithKline Key News & Latest Developments
Table 46. Johnson & Johnson Company Summary
Table 47. Johnson & Johnson Nicotine Replacement Therapy for Smoking Cessation Product Offerings
Table 48. Johnson & Johnson Nicotine Replacement Therapy for Smoking Cessation Revenue (US$, Mn) & (2018-2023)
Table 49. Johnson & Johnson Key News & Latest Developments
Table 50. Philip Morris Company Summary
Table 51. Philip Morris Nicotine Replacement Therapy for Smoking Cessation Product Offerings
Table 52. Philip Morris Nicotine Replacement Therapy for Smoking Cessation Revenue (US$, Mn) & (2018-2023)
Table 53. Philip Morris Key News & Latest Developments
Table 54. Perrigo Company Company Summary
Table 55. Perrigo Company Nicotine Replacement Therapy for Smoking Cessation Product Offerings
Table 56. Perrigo Company Nicotine Replacement Therapy for Smoking Cessation Revenue (US$, Mn) & (2018-2023)
Table 57. Perrigo Company Key News & Latest Developments
Table 58. Alkalon Company Summary
Table 59. Alkalon Nicotine Replacement Therapy for Smoking Cessation Product Offerings
Table 60. Alkalon Nicotine Replacement Therapy for Smoking Cessation Revenue (US$, Mn) & (2018-2023)
Table 61. Alkalon Key News & Latest Developments
Table 62. Ventus Medical Company Summary
Table 63. Ventus Medical Nicotine Replacement Therapy for Smoking Cessation Product Offerings
Table 64. Ventus Medical Nicotine Replacement Therapy for Smoking Cessation Revenue (US$, Mn) & (2018-2023)
Table 65. Ventus Medical Key News & Latest Developments
List of Figures
Figure 1. Nicotine Replacement Therapy for Smoking Cessation Segment by Type in 2022
Figure 2. Nicotine Replacement Therapy for Smoking Cessation Segment by Application in 2022
Figure 3. Global Nicotine Replacement Therapy for Smoking Cessation Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Nicotine Replacement Therapy for Smoking Cessation Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Nicotine Replacement Therapy for Smoking Cessation Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Nicotine Replacement Therapy for Smoking Cessation Revenue in 2022
Figure 8. By Type - Global Nicotine Replacement Therapy for Smoking Cessation Revenue Market Share, 2018-2029
Figure 9. By Application - Global Nicotine Replacement Therapy for Smoking Cessation Revenue Market Share, 2018-2029
Figure 10. By Type - Global Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Nicotine Replacement Therapy for Smoking Cessation Revenue Market Share, 2018-2029
Figure 12. By Application - Global Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Nicotine Replacement Therapy for Smoking Cessation Revenue Market Share, 2018-2029
Figure 14. By Region - Global Nicotine Replacement Therapy for Smoking Cessation Revenue Market Share, 2018-2029
Figure 15. By Country - North America Nicotine Replacement Therapy for Smoking Cessation Revenue Market Share, 2018-2029
Figure 16. US Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Nicotine Replacement Therapy for Smoking Cessation Revenue Market Share, 2018-2029
Figure 20. Germany Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2018-2029
Figure 21. France Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Nicotine Replacement Therapy for Smoking Cessation Revenue Market Share, 2018-2029
Figure 28. China Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2018-2029
Figure 32. India Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Nicotine Replacement Therapy for Smoking Cessation Revenue Market Share, 2018-2029
Figure 34. Brazil Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Nicotine Replacement Therapy for Smoking Cessation Revenue Market Share, 2018-2029
Figure 37. Turkey Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Nicotine Replacement Therapy for Smoking Cessation Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer Nicotine Replacement Therapy for Smoking Cessation Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Cipla Nicotine Replacement Therapy for Smoking Cessation Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis Nicotine Replacement Therapy for Smoking Cessation Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. GlaxoSmithKline Nicotine Replacement Therapy for Smoking Cessation Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Johnson & Johnson Nicotine Replacement Therapy for Smoking Cessation Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Philip Morris Nicotine Replacement Therapy for Smoking Cessation Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Perrigo Company Nicotine Replacement Therapy for Smoking Cessation Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Alkalon Nicotine Replacement Therapy for Smoking Cessation Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Ventus Medical Nicotine Replacement Therapy for Smoking Cessation Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 禁煙用ニコチン代替療法のグローバル市場展望 2023年-2029年：スプレー＆吸入器、ガム、パッチ、トローチ(Nicotine Replacement Therapy for Smoking Cessation Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

禁煙用ニコチン代替療法のグローバル市場展望 2023年-2029年：スプレー＆吸入器、ガム、パッチ、トローチ

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp